Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID‐19 in type 2 diabetes

Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID‐19 in type 2 diabetes

Abstract Early in the COVID‐19 pandemic, type 2 diabetes (T2D) was marked as a risk factor for severe disease and mortality. Inflammation is central to the aetiology of both conditions where variations in immune responses can mitigate or aggravate disease course. Identifying at‐risk groups based on...

Full description

Bibliographic Details
Main Authors: Fawaz Alzaid, Jean‐Baptiste Julla, Marc Diedisheim, Charline Potier, Louis Potier, Gilberto Velho, Bénédicte Gaborit, Philippe Manivet, Stéphane Germain, Tiphaine Vidal‐Trecan, Ronan Roussel, Jean‐Pierre Riveline, Elise Dalmas, Nicolas Venteclef, Jean‐François Gautier
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:EMBO Molecular Medicine
Subjects:
COVID‐19
inflammation
monocyte
SARS‐CoV-2
type 2 diabetes
Online Access:https://doi.org/10.15252/emmm.202013038

Internet

https://doi.org/10.15252/emmm.202013038

Similar Items